Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Immunotherapy -- ethics. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
HIV infections -- Immunotherapy. : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano
2010
1
Immunotherapy -- legislation & jurisprudence. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
2004
1
Leukemia -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy
2017
1
Lymphomas -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy
Multiple sclerosis -- Immunotherapy. : Multiple sclerosis immunology : a foundation for current and future treatments / Takashi Yamamura, Bruno Gran, editors
2013
1
Mycoses -- Immunotherapy. : Antifungal agents : methods and protocols / edited by Erika J. Ernst and P. David Rogers
Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect